MAR 09, 2022 8:00 AM PST

Biosecurity for Genome Engineering: Safety First and the SeqScreen Solution for Functional Predictions

Sponsored by: Inscripta
C.E. Credits: P.A.C.E. CE Florida CE
Speakers

Abstract
Date:  March 09, 2022
Time: 08:00am (PST),  11:00am (EST), 5:00pm (CEST)
 
Bioengineering technologies hold enormous potential to solve many of our world’s pressing problems. However, they also pose biosecurity considerations. Inscripta® is committed to safe use of its genome engineering technology and has implemented multi-faceted biosecurity system designed to identify and help prevent biorisk potential of engineered organisms.  Drs. Ternus, Treangen, and Vitalis will describe approaches and challenges of genome engineering biosecurity and highlight a computational tool that can predict protein function of large numbers of engineered sequence variants.  The SeqScreen platform was developed by a multi-institutional team led by Signature Science and Rice University under the IARPA Fun GCAT program. Case studies will illustrate how SeqScreen serves as a comprehensive tool to report features and predicted function of novel sequences arising from bioengineering.
 
Learning Objectives
  • Recognize the import of biosecurity in Genome Engineering and other advanced bioengineering technologies
  • Explain how proactive screening can help prevent biorisk in Genome Engineering
  • Discuss challenges to predict and characterize biorisk in engineered organisms
  • Describe how the computational platform, SeqScreen, leverages databases, algorithms, and curations to characterize sequences
  • Explore example scenarios in which SeqScreen predicts function of novel sequences arising from bioengineering
 
Webinars will be available for unlimited on-demand viewing after live event.
 
LabRoots is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program. By attending this webinar, you can earn 1 Continuing Education credit once you have viewed the webinar in its entirety.

Show Resources
Show Resources
Connect with us